Mount Sinai Morningside · 1 day ago
Postdoctoral Fellow-MSH-21015-064
Mount Sinai Morningside is dedicated to advancing health through innovative research and education. The Postdoctoral Fellow will develop novel nanotherapeutics and imaging probes to study the innate immune system, collaborating with multidisciplinary teams to translate findings into clinical applications.
Hospital & Health Care
Responsibilities
You will use •in vitro• assays and small- and large-animal models to unravel how the innate immune system regulates health and disease, including allograft rejection, atherosclerosis, and breast cancer
This will involve extensive collaboration with chemists, nanomedicine experts, and •in vivo• imaging specialists to develop novel tools for diagnosis and treatment and initiate their clinical translation
You will also share your results through scientific publications and oral presentations and function as part of a highly motivated multidisciplinary team
Qualification
Required
A Ph.D. in immunology or a comparable discipline
Profound experience in common immunological assays, including flow cytometry, ELISA, Western Blotting, RNA-sequencing, metabolic flux analyses, and cell culturing
Excellent communication and writing skills in the English language
You are a team player and excited to collaborate with others
Preferred
Experience in nanomedicine and/or nuclear imaging is highly desirable
Benefits
Affordable housing
An excellent health plan
Multiple other benefits
Company
Mount Sinai Morningside
At Mount Sinai Morningside, we offer exceptional clinical care and research within the comfort of a neighborhood hospital known for compassion and sensitivity.
H1B Sponsorship
Mount Sinai Morningside has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
2024 (3)
2023 (26)
2022 (20)
2021 (6)
2020 (20)
Funding
Current Stage
Late StageLeadership Team
Company data provided by crunchbase